
Join to View Full Profile
Massachusetts General Hospital55 Fruit StreetBoston, MA 02114
Phone+1 617-726-2865
Dr. Dougan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Massachusetts General HospitalFellowship, 2013 - 2015
- Massachusetts General HospitalResidency, 2011 - 2014
- Harvard Medical SchoolClass of 2011
Certifications & Licensure
- MA State Medical License 2017 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis Start of enrollment: 2020 Aug 31
Roles: Principal Investigator, Contact
- Vedolizumab for the Treatment of Collagenous Gastritis Start of enrollment: 2024 Dec 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity.Isabel H Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A Reyes Curcio, Andres E Franceschi
New Microbes and New Infections. 2025-10-01 - Second Mitochondrial Activator of Caspases Mimetics Accelerate Progression of Locally Advanced Head and Neck Cancer.Michael Dougan, Stephanie K Dougan
Journal of Clinical Oncology. 2025-09-03 - Deep Immune Phenotyping Reveals Distinct Immunopathogenesis in Checkpoint Inhibitor-Induced Colitis Compared with Ulcerative Colitis.Giulia Pesch, Ignazio Piseddu, Jan Gaertig, Nora Kramer, Rafaela Kramer
Cancer Immunology Research. 2025-07-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: